Summary
Gamma-aminobutyric acid (GABA) and GABA agonists exhibited biphasic response on forced swimming-induced despair behavior in mice; smaller doses, GABA (100 mg/kg), muscimol (0.05 and 0.1 mg/kg), baclofen (0.5 and 1 mg/kg), sodium valproate (100 mg/kg), piracetam (25 mg/kg), and fengabine (10 and 20 mg/kg) decreasing forced swimming-induced immobility period, while higher doses enhancing the immobility period. GABA, muscimol, and baclofen also reversed reserpine-induced prolongation of the forced swimming-induced immobility. When GABA was administered with antidepressant agents, it potentiated the effect of some classical antidepressants. Bicuculline and picrotoxin, the GABAergic antagonists, by themselves enhanced the forced swimming-induced immobility period, but they had no significant effect on reserpine-induced prolongation of the immobility period. When animals were chronically exposed to forced swimming, there was a gradual increase of the immobility period which was reduced on treatment with GABAergic agents. It is suggested that GABA has a modulatory role in reversing forced swimming-induced despair and also in potentiating the effect of antidepressants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aley KO, Kulkarni SK (1987) Studies on meperidine-induced catelepsy in mice. Meth Find Exp Clin Pharmacol 9:493–496
Baldessarini RJ (1980) Drugs and the treatment of psychiatric disorders. In: Gilman AS, Goodman LS, Gilman A (eds) Pharmacological basis of therapeutics. MacMillan, New York, pp 391–447
Barbaccia ML, Ravizza L, Costa E (1986) Maprotiline: an antidepressant with an unusual pharmacological profile. J Pharmacol Exp Ther 236:307–312
Biswas B, Carlsson A (1978) Effect of intraperitoneally administered GABA on the locomotor activity of mice. Psychopharmacology 59:91–94
Bonanno G, Raiteri M (1987) Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain. Br J Pharmacol 91:237–243
Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147–160
Borsini F, Evangelista S, Meli A (1986) Effect of GABAergic drugs in the behavioral despair test in rats. Eur J Pharmacol 121:265–268
Bowery NG (1982) Baclofen: 10 years on TIPS 3:400–403
DiChiara G, GL (eds) (1981) GABA and the basal ganglia. Adv Biochem Psychopharmacol. Raven Press, New York, 30:129–163
Dunham NW, Miya TS (1957) A note on simple apparatus for detecting neurological deficit in rats and mice. J Am Pharmacist Assoc Sci Ed, vol XLVI, 3, March
Garelis E, Young SN, Lal S, Sourkes TL (1974) Monoamine metabolites in lumbar CSF: The question of their origin in relation to clinical studies. Brain Res 79:1–8
Gold BL, Bowers MB, Roth RH, Sweeney DW (1980) GABA levels in CSF of patients with psychiatric disorders. Am J Psych 137:362–371
Hill DR, Bowery NG, Hudson AL (1984) Inhibition of GABA receptor binding by guanyl nucleotide. J Neurochem 42:652–657
Korf J, Venema K (1983) Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus. J Neurochem 40:946–950
Kulkarni SK, Mehta AK (1985) Purine nucleoside-mediated immobility in mice: Reversal by antidepressants. Psychopharmacology 85:460–463
Kunchandy J, Kulkarni SK (1986) Reversal by α-agonists of diazepam withdrawal hyperactivity in rats. Psychopharmacology 90:198–202
Lloyd KG, Morselli PL, Depoortere H, Fourmer V, Zivkovic B, Scatton B, Broekkamp C, Worms P, Bartholini G (1983) The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials. Pharmacol Biochem Behav 18:957–966
Lloyd KG, Thuret F, Pilc A (1985) Upregulation of GABAB binding sites in rat frontal cortex: A common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther 235:191–199
Malinge M, Bourin M, Colombel MC, Larousse C (1988) Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test. Psychopharmacology 96:104–109
Nagatani T, Sugihara T, Kodaira R (1984) The effect of diazepam and of agents which change GABAergic functions in immobility in mice. Eur J Pharmacol 97:271–275
Parale MP, Kulkarni SK (1986) Clonidine-induced behavioral despair in mice: Reversal by antidepressants. Psychopharmacology 89:171–174
Parale MP, Chakravarti S, Kulkarni SK (1987) Evidence of β-adrenergic involvement in forced swimming-induced behavioral despair of mice. Meth Find Exp Clin Pharmacol 9:35–38
Pericic D, Manev H, Lakic N (1985) Sex differences in the response of rats to drugs affecting GABAergic transmission. Life Sci 36:541–547
Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336
Porsolt RD, Berlin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210
Post RM, Gordon EK, Goodwin FK, Bunney WE Jr (1973) Central norepinephrine in affective illness: MHPG in the cerebrospinal fluid. Science 179:1002–1003
Pycock CJ, Horton RW (1976) Possible GABA mediated control of dopamine dependent behavioral effects from the nucleus accumbens of the rat. Psychopharmacology 49:173–198
Sanger DJ, Joly D, Depoortere H, Zivkovic B, Lloyd KG (1986) Behavioral profile of progabide in test for anxiolytic and antidepressant drugs. In: Bartholini G, Lloyd KG, Morselli PL (eds) GABA and mood disorders. Raven Press, New York, pp 77–84
Schildkraut JJ (1975) The catecholamine hypothesis of affective disorders. A review of supporting evidence. Am J Psych 122:509–522
Shukla VK, Garg SK, Mathur VS, Kulkarni SK (1985) GABAergic dopaminergic and cholinergic interaction in perphenazine-induced catatonia in rats. Arch Int Pharmacodyn Ther 278:236–248
Suzdak PD, Gianutsos G (1985) Parallel changes in GABAergic and noradrenergic receptor sensitivity following chronic administration of antidepressant and GABAergic drugs: A possible role for GABA in affective disorders. Neuropharmacology 24:217–222
Teruel AF, Boix F, Escorihuela RM, Yanez P, Toberia A (1988) Sodium valproate reduces immobility in the behavioral despair test in rats. Eur J Pharmacol 152:1–7
Weiss E, Brunner H, Clerc G, Guibert M, Orofiamma B, Paget R, Robert G, Thillez D, Musch B (1986) Multicenter double-blind study of progabide in depressed patients. In: Bartholini G, Lloyd KG (eds) GABA and mood disorders. Raven Press, New York, pp 182–188
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alev, K.O., Kulkarni, S.K. GABA-mediated modification of despair behavior in mice. Naunyn-Schmiedeberg's Arch Pharmacol 339, 306–311 (1989). https://doi.org/10.1007/BF00173583
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173583